Displaying drugs 14676 - 14700 of 14943 in total
Lactaldehyde
Experimental
RG-7795
Investigational
Propyl Trihydrogen Diphosphate
Experimental
Ethyl Dihydrogen Diphosphate
Experimental
Dibromothymoquinone
At low concentrations, this compound inhibits reduction of conventional hydrophilic electron acceptors, probably acting as a plastoquinone antagonist. At higher concentrations, it acts as an electron acceptor, intercepting electrons either before or at the site of its inhibitory activity. [PubChem]
Experimental
Plinabulin
Investigational
Lauroyl chloride
Experimental
Betaine aldehyde
Experimental
2,3-Dimethyl-1,4-naphthoquinone
Experimental
Acetyl chloride
Experimental
VLTS-589
VLTS-589 consists of plasmid encoding the angiomatrix protein Del-1 in conjunction with poloxamer 188 for the treatment of peripheral vascular disease.
Investigational
BTA9881
BTA9881 is a respiratory syncytial virus (RSV) antiviral drug developed by the Australian company Biota Holdings. It is currently in phase I trials.
Investigational
3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol
Experimental
CHGN111
CHGN111 is an inhibitor of the mitochondrial enzyme CLK-1 which is a demethoxyubiquinone hydroxylase. Numerous parameters of mitochondrial function are altered when the activity of CLK-1 is reduced, which results in a decrease of ROS at critical cellular sites, as well as in a decrease of systemic oxidative stress. It...
Investigational
1-Amino-1-Carbonyl Pentane
Experimental
Acetophenone
Experimental
P-Hydroxybenzaldehyde
Experimental
R1295
R1295 is an integrin antagonist currently in clinical trials for the treatment of rheumatoid arthritis. Integrins are associated to the pathology seen in some of the autoimmune diseases such as rheumatoid arthritis.
Investigational
Lawsone
Experimental
Displaying drugs 14676 - 14700 of 14943 in total